|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16,70,000.00 KRW | -3.58% |
|
+67.00% | +67.00% |
| 09/02 | Indium hits highest prices in a decade on Chinese speculation and supply risks | RE |
| 09/02 | Korea Zinc Q4 operating profit 429 billion won, up 257% from year earlier | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.86 | 7.42 | 5.21 | 3.4 | 3.37 | |||||
Return on Total Capital | 7.95 | 8.9 | 6.22 | 3.94 | 3.91 | |||||
Return On Equity % | 8.26 | 10.95 | 9.41 | 5.65 | 2.26 | |||||
Return on Common Equity | 8.37 | 11.07 | 9.38 | 5.72 | 2.28 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 13.63 | 12.58 | 10.4 | 9.89 | 9.43 | |||||
SG&A Margin | 1.62 | 1.46 | 1.99 | 2.7 | 2.96 | |||||
EBITDA Margin % | 15.51 | 13.89 | 10.9 | 10.06 | 8.93 | |||||
EBITA Margin % | 11.84 | 10.99 | 8.24 | 6.85 | 6.12 | |||||
EBIT Margin % | 11.84 | 10.99 | 8.19 | 6.78 | 6.01 | |||||
Income From Continuing Operations Margin % | 7.58 | 8.13 | 7.12 | 5.5 | 1.62 | |||||
Net Income Margin % | 7.56 | 8.09 | 6.96 | 5.43 | 1.58 | |||||
Net Avail. For Common Margin % | 7.56 | 8.09 | 6.96 | 5.43 | 1.58 | |||||
Normalized Net Income Margin | 7.41 | 6.68 | 5.17 | 4.44 | 2.15 | |||||
Levered Free Cash Flow Margin | -3.59 | 0.59 | 3.94 | 1.87 | -8.67 | |||||
Unlevered Free Cash Flow Margin | -3.58 | 0.62 | 4.13 | 2.14 | -8.06 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.93 | 1.08 | 1.02 | 0.8 | 0.9 | |||||
Fixed Assets Turnover | 2.48 | 2.98 | 3.11 | 2.53 | 2.71 | |||||
Receivables Turnover (Average Receivables) | 21.1 | 22.26 | 19.83 | 16.86 | 17.97 | |||||
Inventory Turnover (Average Inventory) | 3.44 | 3.38 | 3.51 | 3.2 | 3.4 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.39 | 3.21 | 2.62 | 2.93 | 1.19 | |||||
Quick Ratio | 2.34 | 1.49 | 1.29 | 1.4 | 0.55 | |||||
Operating Cash Flow to Current Liabilities | 0.41 | 0.34 | 0.34 | 0.43 | 0.08 | |||||
Days Sales Outstanding (Average Receivables) | 17.35 | 16.4 | 18.4 | 21.64 | 20.37 | |||||
Days Outstanding Inventory (Average Inventory) | 106.36 | 107.95 | 104.11 | 114.01 | 107.6 | |||||
Average Days Payable Outstanding | 26.67 | 33.08 | 36.27 | 39.66 | 38 | |||||
Cash Conversion Cycle (Average Days) | 97.04 | 91.27 | 86.24 | 96 | 89.97 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 1.93 | 5.77 | 11.37 | 9.6 | 65.46 | |||||
Total Debt / Total Capital | 1.89 | 5.45 | 10.21 | 8.76 | 39.56 | |||||
LT Debt/Equity | 0.25 | 1.79 | 2.6 | 2.29 | 8.01 | |||||
Long-Term Debt / Total Capital | 0.25 | 1.7 | 2.33 | 2.09 | 4.84 | |||||
Total Liabilities / Total Assets | 16.62 | 22.38 | 23.69 | 19.96 | 48.65 | |||||
EBIT / Interest Expense | 538.75 | 263.18 | 26.74 | 15.52 | 6.14 | |||||
EBITDA / Interest Expense | 706.09 | 332.77 | 35.57 | 23.04 | 9.13 | |||||
(EBITDA - Capex) / Interest Expense | 308.56 | 221.4 | 24.72 | 13.16 | -0.32 | |||||
Total Debt / EBITDA | 0.12 | 0.32 | 0.86 | 0.95 | 4.62 | |||||
Net Debt / EBITDA | -1.73 | -1.15 | -1.06 | -1.17 | 2.19 | |||||
Total Debt / (EBITDA - Capex) | 0.27 | 0.48 | 1.24 | 1.66 | -133.3 | |||||
Net Debt / (EBITDA - Capex) | -3.95 | -1.73 | -1.53 | -2.06 | -63.19 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 13.25 | 31.59 | 12.45 | -13.5 | 24.2 | |||||
Gross Profit, 1 Yr. Growth % | 8.85 | 21.41 | -7.04 | -17.73 | 18.48 | |||||
EBITDA, 1 Yr. Growth % | 8.43 | 17.84 | -11.78 | -20.13 | 10.28 | |||||
EBITA, 1 Yr. Growth % | 11.42 | 22.18 | -15.72 | -28.05 | 10.84 | |||||
EBIT, 1 Yr. Growth % | 11.43 | 22.15 | -16.16 | -28.44 | 10.13 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -9.99 | 41.1 | -1.58 | -33.18 | -63.48 | |||||
Net Income, 1 Yr. Growth % | -9.48 | 40.81 | -3.25 | -32.46 | -63.79 | |||||
Normalized Net Income, 1 Yr. Growth % | 5.17 | 18.61 | -12.97 | -25.79 | -39.75 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -9.48 | 40.81 | -5.87 | -39.16 | -63.7 | |||||
Accounts Receivable, 1 Yr. Growth % | 12.48 | 35.59 | 19.32 | -13.01 | 50.56 | |||||
Inventory, 1 Yr. Growth % | 44.63 | 29.29 | -2.88 | -6.64 | 43.32 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 10.78 | 8.22 | 7.38 | 5.31 | 26.32 | |||||
Total Assets, 1 Yr. Growth % | 8.41 | 17.23 | 21.42 | -0.43 | 22.8 | |||||
Tangible Book Value, 1 Yr. Growth % | 3.88 | 8.8 | 9.45 | 3.86 | -25.36 | |||||
Common Equity, 1 Yr. Growth % | 3.79 | 9.15 | 18.86 | 3.84 | -21.9 | |||||
Cash From Operations, 1 Yr. Growth % | -34.09 | 32.94 | 29.3 | 5 | -37.16 | |||||
Capital Expenditures, 1 Yr. Growth % | 84.88 | -29.95 | -19.59 | 12.23 | 166.17 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -207.02 | -121.77 | 645.44 | -58.94 | -675.81 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -206.24 | -122.81 | 648.79 | -55.13 | -567.07 | |||||
Dividend Per Share, 1 Yr. Growth % | 7.14 | 33.33 | 0 | -25 | 16.67 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 4.95 | 22.07 | 21.64 | -1.37 | 3.65 | |||||
Gross Profit, 2 Yr. CAGR % | 7 | 14.96 | 6.24 | -12.54 | -1.27 | |||||
EBITDA, 2 Yr. CAGR % | 7.21 | 13.04 | 1.96 | -16.06 | -6.15 | |||||
EBITA, 2 Yr. CAGR % | 8.33 | 16.68 | 1.48 | -22.13 | -10.7 | |||||
EBIT, 2 Yr. CAGR % | 8.33 | 16.67 | 1.2 | -22.55 | -11.23 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 3.67 | 12.7 | 17.84 | -18.91 | -50.6 | |||||
Net Income, 2 Yr. CAGR % | 4.23 | 12.9 | 16.72 | -19.16 | -50.54 | |||||
Normalized Net Income, 2 Yr. CAGR % | 5.27 | 11.69 | 1.6 | -19.64 | -33.14 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 4.23 | 12.9 | 15.13 | -24.33 | -53.01 | |||||
Accounts Receivable, 2 Yr. CAGR % | 11.94 | 23.49 | 27.2 | 1.88 | 14.44 | |||||
Inventory, 2 Yr. CAGR % | 32.17 | 36.75 | 12.06 | -4.78 | 15.67 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.49 | 9.49 | 7.8 | 6.34 | 15.34 | |||||
Total Assets, 2 Yr. CAGR % | 8.46 | 12.73 | 19.3 | 9.95 | 10.58 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.64 | 6.31 | 9.12 | 6.62 | -11.96 | |||||
Common Equity, 2 Yr. CAGR % | 5.6 | 6.44 | 13.9 | 11.1 | -9.94 | |||||
Cash From Operations, 2 Yr. CAGR % | -28.31 | -6.4 | 31.1 | 16.3 | -18.77 | |||||
Capital Expenditures, 2 Yr. CAGR % | 44.72 | 13.8 | -24.95 | -5 | 72.84 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -20.31 | -51.73 | 27.39 | 74.95 | 53.77 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -20.53 | -50.77 | 30.69 | 83.3 | 44.77 | |||||
Dividend Per Share, 2 Yr. CAGR % | 16.77 | 19.52 | 15.47 | -13.4 | -6.46 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.75 | 13.17 | 18.78 | 8.58 | 6.5 | |||||
Gross Profit, 3 Yr. CAGR % | -1.07 | 11.61 | 7.1 | -2.44 | -3.23 | |||||
EBITDA, 3 Yr. CAGR % | 1.57 | 10.64 | 4.07 | -6.01 | -8.07 | |||||
EBITA, 3 Yr. CAGR % | 0.1 | 12.76 | 4.69 | -9.51 | -12.4 | |||||
EBIT, 3 Yr. CAGR % | 0.1 | 12.75 | 4.5 | -9.84 | -12.9 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -3.21 | 14.89 | 7.72 | -2.46 | -37.84 | |||||
Net Income, 3 Yr. CAGR % | -3.07 | 15.22 | 7.24 | -2.73 | -38.15 | |||||
Normalized Net Income, 3 Yr. CAGR % | -0.31 | 9.54 | 2.78 | -8.5 | -27 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -3.07 | 15.22 | 6.26 | -6.92 | -40.76 | |||||
Accounts Receivable, 3 Yr. CAGR % | 5.86 | 19.33 | 22.09 | 12.06 | 16.04 | |||||
Inventory, 3 Yr. CAGR % | 18.41 | 31.21 | 22.01 | 5.44 | 9.13 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 5.99 | 7.73 | 8.78 | 6.96 | 12.62 | |||||
Total Assets, 3 Yr. CAGR % | 6.49 | 11.3 | 15.55 | 12.33 | 14.08 | |||||
Tangible Book Value, 3 Yr. CAGR % | 5.37 | 6.68 | 7.35 | 7.34 | -5.33 | |||||
Common Equity, 3 Yr. CAGR % | 5.35 | 6.77 | 10.43 | 10.45 | -1.22 | |||||
Cash From Operations, 3 Yr. CAGR % | -16.94 | -11.93 | 4.25 | 21.6 | -5.28 | |||||
Capital Expenditures, 3 Yr. CAGR % | 10.04 | 13.63 | 1.36 | -14.17 | 33.93 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 6.81 | -48.29 | 20.2 | -12.66 | 160.24 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 6.6 | -47.58 | 21.98 | -8.48 | 150.36 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | 22.05 | 12.62 | 0 | -4.35 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.7 | 11.28 | 11.21 | 7.11 | 12.48 | |||||
Gross Profit, 5 Yr. CAGR % | 4.21 | 5.91 | 1.79 | 1.23 | 3.67 | |||||
EBITDA, 5 Yr. CAGR % | 6.8 | 7.18 | 1.72 | -0.93 | -0.14 | |||||
EBITA, 5 Yr. CAGR % | 5.95 | 7.58 | 0.65 | -2.76 | -1.76 | |||||
EBIT, 5 Yr. CAGR % | 5.95 | 7.57 | 0.54 | -2.97 | -2.1 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 2.26 | 6.41 | 4.71 | -0.05 | -21.14 | |||||
Net Income, 5 Yr. CAGR % | 2.38 | 6.37 | 4.41 | -0.01 | -21.31 | |||||
Normalized Net Income, 5 Yr. CAGR % | 5.44 | 5.78 | 0.45 | -3.22 | -13.46 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 2.38 | 6.37 | 3.84 | -2.61 | -23.33 | |||||
Accounts Receivable, 5 Yr. CAGR % | 8.17 | 8.96 | 13.93 | 12.01 | 18.97 | |||||
Inventory, 5 Yr. CAGR % | 17.25 | 19.3 | 15.83 | 15.42 | 19.43 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.79 | 6.99 | 6.71 | 7.17 | 11.36 | |||||
Total Assets, 5 Yr. CAGR % | 7.55 | 8.98 | 11.44 | 10.76 | 13.54 | |||||
Tangible Book Value, 5 Yr. CAGR % | 6.56 | 6.58 | 6.85 | 6.66 | -0.83 | |||||
Common Equity, 5 Yr. CAGR % | 6.54 | 6.64 | 8.69 | 8.48 | 1.78 | |||||
Cash From Operations, 5 Yr. CAGR % | -13.54 | -2.27 | -0.31 | -1.57 | -5.73 | |||||
Capital Expenditures, 5 Yr. CAGR % | 6.65 | 20.25 | -5.58 | 5.77 | 25.48 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -4.62 | -31.53 | 14.61 | -15.8 | 32.64 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -4.75 | -30.96 | 15.65 | -13.51 | 30.63 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | 6.4 | 4.56 |
- Stock Market
- Equities
- A010130 Stock
- Financials Korea Zinc Company, Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















